Thrombosis Panel
Thrombosis blood test panel measuring clotting, fibrinolysis, and inflammation markers to interpret results together and guide next steps with your clinician.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, meaning you get multiple clot-related blood tests in one order. It is designed to help you and your clinician look at clotting tendency, clot breakdown (fibrinolysis), and inflammation together—because a single number (especially D-dimer) can be misleading when it is viewed in isolation.
Do I need this panel?
You might consider a thrombosis panel if you have a history of a blood clot (deep vein thrombosis or pulmonary embolism), especially if you are trying to understand whether your clot was “provoked” (triggered by surgery, immobility, estrogen therapy, pregnancy, or a temporary illness) or whether there may be ongoing risk signals worth discussing with your clinician.
This panel can also be reasonable when you have persistent clotting concerns after a viral illness (including long COVID) and you want a broader, calmer view than repeating a single test like D-dimer. Many people feel stuck between anxiety and uncertainty—normal imaging but ongoing symptoms, or an abnormal lab that does not match how they feel. A multi-marker panel can help you frame the question more clearly: is there evidence of active clot formation, impaired clot breakdown, inflammation-driven clot risk, or medication effects?
This panel is not a way to diagnose a clot at home. If you have symptoms that could represent an acute clot—new or worsening shortness of breath, chest pain, coughing blood, one-sided leg swelling/pain, fainting, or stroke-like symptoms—emergency evaluation is non-negotiable. Lab testing supports clinician-directed care and helps with context, follow-up, and monitoring, but it does not replace urgent imaging and examination when a clot is suspected.
Results and reference ranges vary by lab and method; your clinician should interpret this panel in context of symptoms, imaging, medications (especially anticoagulants), pregnancy status, and recent illness or surgery.
Lab testing
Order the Thrombosis Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault lets you order this thrombosis lab panel and review the results in one place, so you can focus on patterns across markers instead of chasing single numbers. This is especially helpful if you are monitoring recovery after a clot, checking whether inflammation may be contributing to clot risk signals, or trying to understand why a D-dimer result does not match your clinical picture.
After your results are in, you can use PocketMD to ask targeted questions like: “Which results could be elevated from recent infection or exercise?”, “How might my anticoagulant affect PT/INR or aPTT?”, and “Which findings would make follow-up with hematology more urgent?” The goal is to help you prepare for a productive clinician visit with clearer next steps.
If your situation changes quickly or you develop red-flag symptoms, use PocketMD for urgency triage language and seek in-person or emergency care when appropriate. This panel is best used for context, follow-up, and monitoring—not for ruling out an acute clot on your own.
- One order, multiple coagulation-adjacent markers to interpret together
- Designed for trend tracking over time when your clinician recommends monitoring
- PocketMD support for organizing questions and understanding multi-marker patterns
Key benefits of the Thrombosis Panel
- Gives you a multi-marker view of clot formation, clot breakdown, and inflammation—rather than relying on D-dimer alone.
- Helps separate medication effects (like anticoagulants) from underlying coagulation patterns when interpreted with your care team.
- Supports follow-up after a known clot by providing context for recovery, recurrence risk discussions, and monitoring plans.
- Clarifies when an “abnormal” single result may be nonspecific (recent illness, surgery, pregnancy, intense exercise) versus part of a consistent pattern.
- Provides a structured way to discuss persistent post-viral symptoms and clotting concerns under clinician care.
- Can guide whether additional targeted testing (genetic thrombophilia workup, antiphospholipid antibodies, imaging, or specialist referral) is worth considering.
- Makes it easier to track trends across time so you and your clinician can compare like-for-like results instead of one-off snapshots.
What is the Thrombosis Panel?
The Thrombosis Panel is a bundled set of blood tests that look at different parts of hemostasis (the body’s system for stopping bleeding) and thrombosis (pathologic clot formation). A clot forms when platelets and clotting proteins create a fibrin mesh; the body also has a counter-system that breaks clots down (fibrinolysis). Inflammation, liver function, kidney function, pregnancy hormones, and medications can shift these systems in ways that change your lab results.
Because thrombosis is rarely explained by a single marker, this panel is built to be read as a pattern. Some results reflect the “clotting cascade” (how quickly blood clots in standardized lab conditions), some reflect clot burden or clot turnover (like D-dimer), and others reflect background conditions that can push clot risk up or down (like inflammation markers or platelet count).
A key limitation is that many coagulation tests are context-sensitive. For example, D-dimer can rise from infection, inflammation, trauma, surgery, pregnancy, and even strenuous exercise—so a high value does not automatically mean you have a clot. Likewise, PT/INR and aPTT can be altered by anticoagulants, liver disease, factor deficiencies, and lab-specific reagents. The panel is most useful when you interpret it alongside your symptoms, imaging, and medication list.
If you are evaluating an acute possible clot, imaging and clinical assessment drive decisions. This panel is better suited for follow-up, risk-context conversations, and monitoring when your clinician agrees it is appropriate.
What this panel can and cannot tell you
This panel can show whether your results look consistent with increased clot turnover, inflammation-associated clot risk signals, or medication-driven changes in clotting times. It cannot confirm or exclude a clot by itself, and it does not replace a dedicated thrombophilia evaluation when that is clinically indicated (for example, recurrent unprovoked clots, clots at unusual sites, or strong family history).
Why D-dimer needs context
D-dimer is a breakdown product of cross-linked fibrin. It is sensitive for clot turnover but not specific for thrombosis. A normal D-dimer can be reassuring in certain low-risk clinical scenarios, but a high D-dimer is common in many non-clot conditions. In a panel, D-dimer is most informative when you also look at inflammation markers, fibrinogen, platelet count, and whether you are on anticoagulation.
What do my panel results mean?
Patterns that can look “low” across the panel
A “low” pattern in a thrombosis panel usually means there is not much evidence of active clot turnover or systemic activation at the time of the draw—for example, D-dimer not elevated and inflammatory markers not elevated. Sometimes “low” shows up as longer clotting times (higher PT/INR or aPTT) rather than low values, which can reflect anticoagulant use, factor deficiency, liver disease, or lab-specific effects. If you are taking a blood thinner, a pattern that looks “less clottable” on paper may be expected and does not automatically indicate a bleeding disorder; it is a prompt to confirm medication timing and the intended monitoring strategy with your clinician.
Patterns that are often considered reassuring
A reassuring pattern is when clotting times are in the expected range for your situation (including expected changes if you are on anticoagulation), platelet count is not elevated, fibrinogen is not markedly high, and D-dimer is not elevated in a way that conflicts with your clinical context. In follow-up after a clot, stability over time is often as important as any single value. If your symptoms are stable and imaging has ruled out acute thrombosis, a panel that does not show escalating activation can support a calmer plan: continue clinician-directed therapy, address reversible risk factors, and recheck only when it would change decisions.
Patterns that can look “high” or more activated
A more activated pattern can include elevated D-dimer (suggesting increased clot turnover), elevated fibrinogen and/or inflammatory markers (suggesting an inflammation-driven prothrombotic state), and sometimes higher platelet counts. This pattern does not diagnose a clot, but it can raise the importance of clinical context: recent infection (including post-viral states), surgery, trauma, pregnancy/postpartum status, cancer evaluation when appropriate, or autoimmune conditions. If you have new red-flag symptoms, high-activation patterns should push you toward urgent clinical evaluation rather than repeat testing at home. If you feel well and imaging is negative, your clinician may focus on identifying the driver of inflammation or other triggers and deciding whether follow-up testing or specialist care is warranted.
Factors that influence thrombosis panel results
Many factors can shift this panel. Anticoagulants (warfarin, heparin, direct oral anticoagulants) can change PT/INR and/or aPTT and may affect interpretation of clotting assays; always document the drug, dose, and timing. Recent surgery, trauma, intense exercise, infection, and chronic inflammatory conditions can raise D-dimer, fibrinogen, and CRP without an acute clot. Pregnancy and the postpartum period naturally increase several clotting factors and can elevate D-dimer. Liver disease can reduce clotting factor production and alter PT/INR; kidney disease and malignancy can also change coagulation balance. Finally, pretest probability matters: if your clinical likelihood of an acute clot is high, a “normal-ish” panel should not delay imaging and urgent care.
What’s included in this panel
- Activated Protein C Resistance
- Antithrombin Iii Activity
- Protein C, Activity
- Protein S, Activity
Frequently Asked Questions
Do I need to fast for the Thrombosis Panel?
Fasting is usually not required for coagulation and inflammation markers. If you are combining this panel with other labs (like lipids or glucose/insulin testing), fasting instructions may change. Follow the instructions shown at checkout and note your medication timing.
Can this panel diagnose a blood clot (DVT or PE)?
No. This panel cannot diagnose or rule out an acute clot by itself. If you have symptoms concerning for DVT/PE, you need urgent clinical evaluation and imaging. The panel is most useful for context, follow-up, and monitoring under clinician care.
Why is my D-dimer high if my imaging was normal?
D-dimer is sensitive but not specific. It can be elevated with infection, inflammation, recent surgery or trauma, pregnancy/postpartum changes, liver disease, cancer, and even strenuous exercise. A high D-dimer with normal imaging often shifts the question from “Do I have a clot right now?” to “What is driving clot turnover or inflammation, and do I need follow-up?”
How do blood thinners affect these results?
Anticoagulants can change clotting time tests (PT/INR and/or aPTT) and can complicate interpretation of some coagulation assays. Always record the exact medication, dose, and when you took it relative to the blood draw. Your clinician may prefer specific monitoring tests depending on the drug.
Should I order individual tests instead of a panel?
If you already know exactly what question you are answering (for example, a single follow-up marker your clinician requested), individual tests can be appropriate. A panel is helpful when you want a broader pattern—especially when a single marker like D-dimer has been confusing or anxiety-provoking.
How often should I repeat this panel?
There is no universal schedule. Repeat testing is most useful when it would change a decision—such as monitoring recovery after a clot, tracking an inflammation-driven pattern, or reassessing after a medication change. Your clinician can help you choose timing so you avoid unnecessary testing and false alarms.
When should I seek emergency care instead of ordering labs?
Seek emergency care for symptoms that could represent an acute clot: new or worsening shortness of breath, chest pain, coughing blood, one-sided leg swelling/pain/redness, fainting, severe headache, or stroke-like symptoms (face droop, weakness, speech changes). Do not wait for lab results in these situations.